Clinical Trials Logo

Clinical Trial Summary

The goal of the energy-based devices used in this study is to evaluate their safety and performance to treat unwanted dermatologic conditions.


Clinical Trial Description

Up to 50 subjects will be enrolled at 1 study center. Subjects will be enrolled into 4 groups: Group A, Group B, Group C, or Group D. Subjects may enroll in more than one group, however the last treatment in the previous group would be at least 30 days before the subject is enroll in the next group if treatment area is the same. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06111482
Study type Interventional
Source Cynosure, Inc.
Contact Jamie Trimper
Phone 9782564200
Email jamie.trimper@cynosure.com
Status Recruiting
Phase N/A
Start date September 28, 2023
Completion date February 2025

See also
  Status Clinical Trial Phase
Recruiting NCT02296450 - Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
Completed NCT06023303 - Prospective Clinical Study to Assess Safety and to Collect Data on Radiofrequency Microneedling Device(s) For the Purpose of Evaluating Treatment on Skin N/A
Recruiting NCT02471352 - Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
Completed NCT06059417 - Foam Tape Allergy a Sticky Situation N/A
Completed NCT02122432 - Teledermatology Versus Usual Care on Delay Before Diagnosis and Treatment of Dermatologic Conditions N/A